Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

DABUR TO SET UP UNIT IN UK FOR ANTI-CANCER DRUGS

Article Abstract:

Dabur India Ltd is setting up a unit in the UK for manufacturing oncology products as a first step towards becoming an international player in the anti-cancer business. The new facility will cater to the markets in Europe and the Middle East. The company, which already has a 100 percent subsidiary called Axol Laboratories in the UK, does not plan to market the oncology products under the Dabur brand name. The facility will begin commercial operations only after obtaining all the necessary approvals, which is expected to take about 12 to 15 months. (khr)

Comment:

Dabur India Ltd is setting up a unit in the UK for manufacturing oncology products as a first step towards becoming an international player in the anti-cancer business.

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1999
United Kingdom, New capacity, new plant construction, Research and Development in the Physical, Engineering, and Life Sciences, Medical Research, Dabur India Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


BIRLA 3M LIMITED

Article Abstract:

Birla 3M Ltd of Bangalore has declared its unaudited financial results for the quarter and half-year ended September 30, 1998. (khr)

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: GALFAR TO SET UP Rs10-CRORE CENTRE IN KERALA LEELA'S CONVENTION CENTRE PLAN SHELVED. SRS CHECKING INTO INDIA
  • Abstracts: BUCKEYE TO SET UP EXECUTIVE PARK PFs DEVELOP APPETITE FOR PRIVATE SECTOR DEBT, BUY BIG IN 3 ISSUES
  • Abstracts: GACL TO SET UP 1-M T CEMENT PLANT IN LANKA. TCS TIES UP WITH TURKEY'S BILPA. CADD CENTRE TIES UP WITH CEYLINCO OF SRI LANKA
  • Abstracts: ESSKAY PHARMA LAUNCHES MEDICINES IN POUCHES SUN PHARMA INTO ANTI-CANCER DRUGS
  • Abstracts: RIZVI GROUP PLANS TO SET UP SOFTWARE SUBSIDIARY IN US GOLDMAN SACHS RATES INDIA HIGH. BHPV BAGS 8-CR ORDER FROM IOC
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.